Roman Kotlín

Roman Kotlín

Auto-generated profile, based on publicly available information

Roman Kotlín

Institute of Hematology and Blood Transfusion, Praha, Czech Republic

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2008 in Acta Haematologica
Verified
Journal Article
Closed access
RKRoman Kotlín
Roman Kotlín
ASAlžběta Sobotková
Alžběta Sobotková
TRTomáš Riedel
Tomáš Riedel
PSPeter Salaj
Peter Salaj
JSJiří Suttnar
Jiří Suttnar
JDJan E. Dyr
Jan E. Dyr
Abnormal coagulation properties indicative of a dysfibrinogen were found in the plasma of a 72-year-old male with multiple myeloma (IgGĸ, stage IIIA). The patient had high paraprotein concentration (85.75 g/l) and prolonged thrombin time (76.8 s), activated partial thromboplastin time (39.5 s), prothrombin time (23.5 s) and reptilase time (72.0 s). The fibrinogen level was increased. The fibrin polymerization induced by both thrombin and reptilase was impaired. Scanning electron microscopy revealed abnormal clot morphology. After six months of treatment, the paraprotein level decreased (19.48 g/l) and coagulation normalized as well as fibrin polymerization and fibrin clot morphology. It was found that the paraprotein interacts with the γ-chain of fibrinogen. Acquired dysfibrinogenemia associated with multiple myeloma was diagnosed in the 72-year-old patient.

1 January 2009 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
ZRZuzana Reicheltová
Zuzana Reicheltová
Martin MalyMartin Maly
Martin Maly
JSJiri Suttnar
Jiri Suttnar
ASAlžbòta Sobotková
Alžbòta Sobotková
PSPeter Salaj
Peter Salaj
RKRoman Kotlín
Roman Kotlín
Congenital dysfibrinogenemia is a rare disease characterised by inherited abnormality in the fibrinogen molecule, resulting in functional defects. Two patients, a 26-year-old woman and a 61-year-old man, both with history of thrombotic events, had abnormal coagulation test results. DNA sequencing showed the heterozygous γY363N mutation (Fibrinogen Praha III) and the heterozygous Aα N106D mutation (Fibrinogen Plzeň), respectively. Fibrin polymerisation, after addition of either thrombin or reptilase, showed remarkably delayed polymerisation in both cases. Fibrinolysis experiments showed slower tPA initiated lysis of clots. SDS-PAGE did not show any difference between normal and Praha III and Plzeň fibrinogens. Both mutations had a significant effect on platelet aggregation. In the presence of either ADP or TRAP, both mutations caused the decrease of platelet aggregation. SEM revealed abnormal clot morphology, with a large number of free ends and narrower fibres of both fibrin Praha III and Plzeň. Praha III mutation was situated in the polymerisation pocket “a”. The replacement of the bulky aromatic side chain of tyrosine by the polar uncharged small side chain of asparagine may lead to a conformational change, possibly altering the conformation of the polymerisation pocket. The Plzeň mutation is situated in the coiled-coil connector and this replacement of polar uncharged asparagine residue by polar acidic aspartate changes the alpha-helical conformation of the coiled-coil connector;and may destabilise hydrogen bonds in its neighborhood. Although both mutations are situated in different regions of the molecule, both mutations have a very similar effect on fibrinogen functions and both are connected with thromboses.

1 January 2007 in Thrombosis Research
Verified
Journal Article
Closed access
RKRoman Kotlín
Roman Kotlín
MCMartina Chytilová
Martina Chytilová
JSJiří Suttnar
Jiří Suttnar
TRTomáš Riedel
Tomáš Riedel
PSPeter Salaj
Peter Salaj
JDJan E. Dyr
Jan E. Dyr

18 July 2010 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
RKRoman Kotlín
Roman Kotlín
ZRZuzana Reicheltová
Zuzana Reicheltová
JSJiří Suttnar
Jiří Suttnar
PSPeter Salaj
Peter Salaj
IHIngrid Hrachovinová
Ingrid Hrachovinová
JDJan Evangelista Dyr
Jan Evangelista Dyr

29 November 2010 in Thrombosis Research
Verified
Journal Article
Closed access
PDF file
RKRoman Kotlín
Roman Kotlín
KZKateřina Zichová
Kateřina Zichová
JSJiří Suttnar
Jiří Suttnar
ZRZuzana Reicheltová
Zuzana Reicheltová
PSPeter Salaj
Peter Salaj
JDJan E. Dyr
Jan E. Dyr

9 March 2012 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
RKRoman Kotlín
Roman Kotlín
JSJiří Suttnar
Jiří Suttnar
IČIrena Čápová
Irena Čápová
IHIngrid Hrachovinová
Ingrid Hrachovinová
MUMarie Urbánková
Marie Urbánková
JDJan Evangelista Dyr
Jan Evangelista Dyr